Back
Zevra Therapeutics Stock Price Chart
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
ZVRA
Zevra Therapeutics
Last Price:
$8.22
Seasonality Move:
-11.97%
7 Day Trial
ALL ACCESS PASS
$
7
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight buying pressure.
Zevra Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.06 | Sell |
| 20-day SMA: | 7.86 | Buy |
| 50-day SMA: | 7.93 | Buy |
| 200-day SMA: | 7.44 | Buy |
| 8-day EMA: | 8.02 | Sell |
| 20-day EMA: | 7.95 | Buy |
| 50-day EMA: | 8 | Buy |
| 200-day EMA: | 7.51 | Buy |
Zevra Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 51.68 | Buy |
| Chaikin Money Flow: | 92007 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.6 - 8.14) | Buy |
| Bollinger Bands (100): | (7.78 - 8.86) | Sell |
Zevra Therapeutics Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zevra Therapeutics Stock
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 8.01 while ZVRA 8-day simple moving average is 8.06, which is a Sell signal.
-
The stock price of ZVRA is 8.01 while Zevra Therapeutics 20-day SMA is 7.86, which makes it a Buy.
-
Zevra Therapeutics 50-day simple moving average is 7.93 while ZVRA share price is 8.01, making it a Buy technically.
-
ZVRA stock price is 8.01 and Zevra Therapeutics 200-day simple moving average is 7.44, creating a Buy signal.
ZVRA Technical Analysis vs Fundamental Analysis
Sell
37
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics a Buy or a Sell?
-
Zevra Therapeutics stock is rated a SellThe current Zevra Therapeutics [ZVRA] share price is $8.01. The Score for ZVRA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Zevra Therapeutics Stock Info
Market Cap:
433.5M
Price in USD:
8.01
Share Volume:
1.7M
Zevra Therapeutics 52-Week Range
52-Week High:
9.76
52-Week Low:
4.20
Sell
37
Zevra Therapeutics (ZVRA)
is a Sell
Zevra Therapeutics Share Price Forecast
-
What is the Zevra Therapeutics stock price today?The Zevra Therapeutics stock price is 8.01 USD today.
-
Will ZVRA stock go up or go down?Zevra Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Zevra Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics is overvalued.
Is Zevra Therapeutics Stock a Buy?
-
Zevra Therapeutics share price is 8.01 while ZVRA 8-day exponential moving average is 8.02, which is a Sell signal.
-
The stock price of ZVRA is 8.01 while Zevra Therapeutics 20-day EMA is 7.95, which makes it a Buy.
-
Zevra Therapeutics 50-day exponential moving average is 8.00 while ZVRA share price is 8.01, making it a Buy technically.
-
ZVRA stock price is 8.01 and Zevra Therapeutics 200-day simple moving average is 7.51, creating a Buy signal.
Fundamental Analysis of Zevra Therapeutics
Is Zevra Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.04 per share, and an increase next year of $0.54 per share.
Technical Analysis of Zevra Therapeutics
Should I short Zevra Therapeutics stock?
-
ZVRA Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting Zevra Therapeutics is a Buy
-
Zevra Therapeutics Relative Strength Index (RSI) is 51.68, which suggest Zevra Therapeutics is overbought
-
The Bollinger Bands (25) for Zevra Therapeutics is (7.6 - 8.14), which suggest Zevra Therapeutics is a Sell
-
The Bollinger Bands (100) for Zevra Therapeutics is (7.78 - 8.86), which suggest Zevra Therapeutics is a Sell
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.